Neumedicines Inc. is an IL-12 based treatments founded in 2003 by Lena A Basile.
IL-12 based treatments
Neumedicines Inc. is a therapeutic biotechnology company focused on developing and commercializing proprietary products and approaches that address clinical and societal needs in the areas of oncology, hematology, and immunology.